From shifting regulatory tides in Latin America, this issue brings you fresh insights on where global clinical research is heading next. Whether you’re planning your next FIH study or evaluating trial-ready markets, here
FIH · clinical trial · clinical research · regulatory · FDA · MedTech
From shifting regulatory tides in Latin America, this issue brings you fresh insights on where global clinical research is heading next. Whether you’re planning your next FIH study or evaluating trial-ready markets, here’s what’s catching attention:
An emerging market is establishing itself as a launchpad for pre-MDR Medtech studies LATAM’s clinical trial market is projected to hit $8B within a decade A novel corneal therapy fast-tracks through the FDA pipeline
It’s a good moment to look ahead 👇
← All Global Trial Accelerators editions · Contact bioaccess®